Equities

Angelalign Technology Inc

Angelalign Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (HKD)59.65
  • Today's Change-1.25 / -2.05%
  • Shares traded361.41k
  • 1 Year change-1.89%
  • Beta1.4355
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ANGELALIGN TECHNOLOGY Inc is a clear aligner dental treatment solution provider. The Company provides dental professionals with self-developed digital orthodontics solutions. The Company’s Angelalign clear aligner system facilitate dental professionals throughout the entire clear aligner treatment process, include digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, help dental professionals design, review and modify treatment plans; customized, removable clear aligners based on specific treatment plans, is a removable, transparent, plastic form of dental braces used to treat malocclusion; and cloud-based service platform, iOrtho, helps to placing orders, reviewing, modifying and finalizing their treatment plans online with the help from its medical designers, and reviewing, editing and managing medical records of their patients.

  • Revenue in HKD (TTM)1.85bn
  • Net income in HKD46.88m
  • Incorporated2018
  • Employees3.55k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
MicroPort NeuroScientic Corp832.13m241.71m5.41bn534.0022.502.9718.496.500.41550.41551.433.150.38991.178.301,457,322.0010.91--12.61--74.12--27.97--4.53--0.0282--21.61--768.73------
AK Medical Holdings Ltd1.18bn202.79m5.64bn974.0027.682.1118.944.760.18140.18141.062.380.35140.75731.971,125,532.006.029.277.4611.2860.9165.0617.1321.782.58--0.04822.653.9712.74-11.074.6721.675.88
Yidu Tech Inc866.96m-209.41m5.76bn902.00--1.34--6.64-0.1991-0.19910.82444.070.1658114.901.36961,148.50-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96---2.99--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd439.41m231.67m5.99bn239.0025.862.9724.5913.640.66810.66811.275.830.20250.64037.162,006,447.0010.68--11.59--89.26--52.72--5.34--0.0014--31.58--864.81------
Shanghai Conant Optical Co Ltd2.05bn405.16m6.07bn2.76k14.843.8812.952.970.95940.95944.843.670.93532.325.94815,548.5018.5212.5725.2718.6938.3735.2719.8014.641.70--0.130418.5712.7015.5631.5633.0413.49--
New Horizon Health Ltd1.46bn118.83m6.47bn1.04k59.472.0241.834.420.23780.23783.207.010.45362.162.081,666,325.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
LifeTech Scientific Corp1.38bn267.08m6.85bn1.41k24.611.8641.934.980.06010.06010.31110.7940.28770.6179.19951,249.001.817.092.168.5178.5879.666.3022.692.02--0.16350.0015.4817.88-19.0916.8026.11--
Kangji Medical Holdings Ltd1.05bn574.06m7.09bn964.0011.952.8012.466.730.49030.49030.89992.090.2291.835.071,050,468.0011.6414.4016.9016.1879.7881.7550.8457.241.74--0.0031111.8117.7621.235.2828.0041.50--
Shanghai MicroPort MedBot Group Co Ltd167.82m-805.99m8.89bn560.00--29.70--52.97-0.8408-0.84080.17510.30810.1090.45310.52258,180.00-52.93---82.38--25.37---485.67--0.637-6.990.6773--384.16--11.20------
Angelalign Technology Inc1.85bn46.88m10.35bn3.55k219.172.9773.875.600.27790.277910.9620.520.35195.2314.95641,286.600.69665.760.91147.5963.5064.331.9813.982.83--0.1073--16.2424.75-74.99-2.2020.54--
MicroPort Scientific Corp7.99bn-3.21bn11.10bn6.99k--2.02--1.39-1.75-1.754.372.970.26921.134.49971,114.10-14.05-11.85-25.55-18.0455.9362.96-52.19-44.431.65-2.080.5669--13.077.27-9.42--19.44--
QuantumPharm Inc211.71m-2.73bn13.79bn760.00--3.11--65.14-1.07-1.070.10241.30------270,377.20-------------1,280.46------0.038--30.80---33.08------
Data as of Nov 22 2024. Currency figures normalised to Angelalign Technology Inc's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

13.49%Per cent of shares held by top holders
HolderShares% Held
Aegon-Industrial Fund Management Co., Ltd.as of 14 Jun 20238.47m4.99%
Capital Research & Management Co. (World Investors)as of 30 Sep 20245.69m3.35%
E Fund Management Co., Ltd.as of 30 Jun 20242.57m1.51%
The Vanguard Group, Inc.as of 06 Nov 20241.70m1.00%
Nordea Investment Management AB (Denmark)as of 31 Jul 2024895.37k0.53%
China Asset Management Co., Ltd.as of 30 Jun 2024850.40k0.50%
Fidelity Management & Research Co. LLCas of 30 Sep 2024791.76k0.47%
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024785.40k0.46%
GF Fund Management Co., Ltd.as of 30 Jun 2024614.40k0.36%
Capital Research & Management Co. (Global Investors)as of 30 Sep 2024547.35k0.32%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.